Antipsychotics promote the differentiation of oligodendrocyte progenitor cells by regulating oligodendrocyte lineage transcription factors 1 and 2
Abstract
Aims Oligodendrocyte/myelin abnormalities may be an important component of the pathogenesis found in schizophrenia. The aim of this current study was to examine the possible effects of the antipsychotic drugs (APDs) haloperidol (HAL), olanzapine (OLA), and quetiapine (QUE) on the development of oligodendroglial lineage cells.Main methods CG4 cells, an oligodendrocyte progenitor cell line, were treated with various concentrations of HAL, OLA, or QUE for specific periods. The proliferation and differentiation of the CG4 cells were measured. The regulation of CG4 cell differentiation by oligodendrocyte lineage transcription factors 1 and 2 (Olig1 and Olig2) was examined.Key findings The APDs used in this study had no effect on the proliferation of CG4 cells. The APDs elevated the expression of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), a specific marker of oligodendrocytes, and promoted the CG4 cells to differentiate into CNP positive oligodendrocytes. QUE and OLA increased the expression of both Olig1 and Olig2 whereas HAL only increased the expression of Olig2.Significance Our findings suggest that oligodendrocyte development is a target of HAL, OLA, and QUE and provide further evidence of the important role of oligodendrocytes in the pathophysiology and treatment of schizophrenia. They also indicate that the expression level of oligodendrocyte/myelin-related genes could be profoundly affected by APDs, which should be considered in future studies aiming to measure the oligodendrocyte/myelin-related gene expressions in schizophrenia patients.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A positive influence of antipsychotic medication on glia cells and myelination has been demonstrated.
“A positive influence of antipsychotic medication on glia cells and myelination has been demonstrated. 82,83”
From Physical exercise keeps the brain connected: biking increases white matter integrity in patients with schizophrenia and healthy controls. (2015) · cites this paper as [83]
Cites
White matter in learning, cognition, and psychiatric disorders
Fields, R. D. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.04.001 · Cited by 1,337 · see citing works
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192 · see citing works
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036 · see citing works
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
Tkachev, D., Mimmack, M., Ryan, M. M., Wayland, M., Freeman, T., Jones, P., Starkey, M., Webster, M., Yolken, R., & Bahn, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14289-4 · Cited by 940 · see citing works
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933 · see citing works
White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., Buxbaum, J., & Haroutunian, V. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.443 · Cited by 793 · see citing works
Mechanisms of axon ensheathment and myelin growth
Sherman, D. L., & Brophy, P. J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1743 · Cited by 668 · see citing works
Endogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544 · see citing works
Takebayashi, H., Nabeshima, Y., Yoshida, S., Chisaka, O., Ikenaka, K., & Nabeshima, Y. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00926-0 · Cited by 500 · see citing works
Flynn, S. W., Lang, D. J., MacKay, A. L., Goghari, V. M., Vavasour, I. M., Whittall, K. P., Smith, G. N., Arango, V., Mann, J. J., Dwork, A. J., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001337 · Cited by 439 · see citing works
Glial specification in the vertebrate neural tube
Rowitch, D. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1389 · Cited by 432 · see citing works
The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry
Baumann, P., Hiemke, C., Ulrich, S., Eckermann, G., Gaertner, I., Gerlach, M., Kuss, H.-J., Laux, G., Müller-Oerlinghausen, B., Rao, M. L., et al. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832687 · Cited by 425 · see citing works
bHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS
Arnett, H. A., Fancy, S. P. J., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., Raine, C. S., Rowitch, D. H., Franklin, R. J. M., & Stiles, C. D. (2004) · Science · doi:10.1126/science.1103709 · Cited by 416 · see citing works
Louis, J., Magal, E., Muir, D., Manthorpe, M., & Varon, S. S. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310125 · Cited by 414 · see citing works
The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry
Gaertner, I., Baumann, P., Hiemke, C., Ulrich, S., Eckermann, G., Gerlach, M., Kuss, H., Laux, G., Müller-Oerlinghausen, B., Ml, R., et al. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-862645 · Cited by 343 · see citing works
Psychiatric Disturbances in Metachromatic Leukodystrophy
Hyde, T. M. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530280095028 · Cited by 309 · see citing works
Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion
Watanabe, M., Toyama, Y., & Nishiyama, A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10338 · Cited by 261 · see citing works
<i>Olig</i> gene function in CNS development and disease
Ligon, K. L., Fancy, S. P. J., Franklin, R. J. M., & Rowitch, D. H. (2006) · Glia · doi:10.1002/glia.20273 · Cited by 223 · see citing works
Structural Polymorphism and Multifunctionality of Myelin Basic Protein
Harauz, G., Ladizhansky, V., & Boggs, J. M. (2009) · Biochemistry · doi:10.1021/bi901005f · Cited by 213 · see citing works
Xiao, L., Xu, H., Zhang, Y., Wei, Z., He, J., Jiang, W., Li, X., Dyck, L. E., Devon, R. M., Deng, Y., et al. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002064 · Cited by 191 · see citing works
Self-citationDracheva, S. M., Davis, K. L., Chin, B., Woo, D. A., Schmeidler, J., & Haroutunian, V. H. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.012 · Cited by 178 · see citing works
Vogel, U. S., & Thompson, R. J. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02461.x · Cited by 162 · see citing works
Barley, K. M., Dracheva, S. M., & Byne, W. M. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.019 · Cited by 155 · see citing works
Fernø, J., Raeder, M. B., Vik‐Mo, A. O., Skrede, S., Glambek, M., Tronstad, K. J., Breilid, H., Løvlie, R., Berge, R. K., Stansberg, C. T., et al. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500323 · Cited by 152 · see citing works
Bifulco, M., Laezza, C., Stingo, S., & Wolff, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042678799 · Cited by 147 · see citing works
McCullumsmith, R. E., Gupta, D. S., BENEYTO, M., KREGER, E., HAROUTUNIAN, V., Davis, K. L., & Meador‐Woodruff, J. H. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.017 · Cited by 144 · see citing works
Zhang, Y., Zhang, H., Wang, L., Jiang, W., Xu, H., Xiao, L., Bi, X., Wang, J., Zhu, S., Zhang, R., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.04.006 · Cited by 139 · see citing works
Self-citationCheng, X., Wang, Y., He, Q., Qiu, M. S., Whittemore, S. R., & Cao, Q. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0284 · Cited by 132 · see citing works
Georgieva, L., Moskvina, V., Peirce, T., Norton, N., Bray, N. J., Jones, L., Holmans, P., MacGregor, S., Zammit, S., Wilkinson, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603029103 · Cited by 125 · see citing works
Gokhan, S., Marin-Husstege, M., Yung, S.-Y., Fontanez, D. E., Casaccia-Bonnefil, P., & Mehler, M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1850-05.2005 · Cited by 123 · see citing works
Lu, Q. R., Cai, L., Rowitch, D., Cepko, C. L., & Stiles, C. (2001) · Nature Neuroscience · doi:10.1038/nn718 · Cited by 122 · see citing works
A Systematic Genomewide Linkage Study in 353 Sib Pairs with Schizophrenia
Williams, N. M., Norton, N., Williams, H. J., Ekholm, B., Hamshere, M. L., Lindblom, Y., Chowdari, K. V., Cardno, A. G., Zammit, S., Jones, L. A., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/380206 · Cited by 118 · see citing works
Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse
Zhang, Y., Xu, H., Jiang, W., Xiao, L., Yan, B., He, J., Wang, Y., Bi, X., Li, X., & Kong, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.013 · Cited by 118 · see citing works
Self-citationCopray, S. C. V. M., Balasubramaniyan, V., Levenga, J., de Bruijn, J., Liem, R. S. B., & Boddeke, E. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0239 · Cited by 116 · see citing works
Xu, H. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00008 · Cited by 108 · see citing works
Self-citationMitkus, S. N., Hyde, T. M., Vakkalanka, R., Kolachana, B. S., Weinberger, D. R., Kleinman, J. E., & Lipska, B. K. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.032 · Cited by 107 · see citing works
Therapeutic Drug Monitoring of Common Antipsychotics
Patteet, L., Morrens, M., Maudens, K. E. K., Niemegeers, P., Sabbe, B., & Neels, H. M. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182708ec5 · Cited by 106 · see citing works
Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia
Bartzokis, G., Lu, P. H., Nuechterlein, K. H., Gitlin, M. J., Doi, C., Edwards, N. J., Lieu, C. H., Altshuler, L. L., & Mintz, J. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.02.011 · Cited by 94 · see citing works
Bartzokis, G., Lu, P. H., Stewart, S. B., Oluwadara, B., Lucas, A. J., Pantages, J., Pratt, E., Sherin, J. E., Altshuler, L. L., Mintz, J., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.06.014 · Cited by 91 · see citing works
Fernø, J., Skrede, S., Vik‐Mo, A. O., Håvik, B., & Steen, V. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-69 · Cited by 89 · see citing works
Garver, D. L., Holcomb, J. A., & Christensen, J. D. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007730 · Cited by 87 · see citing works
Developmental partitioning of myelin basic protein into membrane microdomains
DeBruin, L. S., Haines, J. D., Wellhauser, L. A., Radeva, G., Schonmann, V., Bienzle, D., & Harauz, G. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20452 · Cited by 81 · see citing works
Bi, X., Zhang, Y., Yan, B., Fang, S., He, J., Zhang, D., Zhang, Z., Kong, J., Tan, Q., & Li, X. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07883.x · Cited by 40 · see citing works
Self-citationNiu, J., Mei, F., Li, N., Wang, H., Li, X., Kong, J., & Xiao, L. (2010) · Biochemistry and Cell Biology · doi:10.1139/o09-178 · Cited by 36 · see citing works
Self-citationByne, W. M., Dracheva, S. M., Chin, B., Schmeidler, J., Davis, K. L., & Haroutunian, V. H. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.034 · Cited by 36 · see citing works
Positive association between OLIG2 and schizophrenia in the Chinese Han population
Huang, K., Tang, W. L., Tang, R., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0434-z · Cited by 29 · see citing works
Kimoto, S., Okuda, A., Toritsuka, M., Yamauchi, T., Makinodan, M., Okuda, H., Tatsumi, K., Nakamura, Y., Wanaka, A., & Kishimoto, T. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.07.011 · Cited by 29 · see citing works
Vogel, U. S., Reynolds, R., Thompson, R. J., et al. (1988) · Glia · doi:10.1002/glia.440010303 · Cited by 27 · see citing works
Olanzapine increases cell mitotic activity and oligodendrocyte-lineage cells in the hypothalamus
Yamauchi, T., Tatsumi, K., Makinodan, M., Kimoto, S., Toritsuka, M., Okuda, H., Kishimoto, T., & Wanaka, A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.07.003 · Cited by 18 · see citing works
Olig1 needed for remyelination
Burton, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)00978-6 · Cited by 15 · see citing works
Zhang, Y., Xu, H., Xiao, L., et al. (2008) · Schizophrenia Research · doi:10.1016/s0920-9964(08)70209-3 · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Svatkova, A., Mandl, R. C. W., Scheewe, T. W., Cahn, W., Kahn, R. S., & Hulshoff Pol, H. E. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv033 · Cited by 120 · see citing works
- Authors
- Fang, F., Zhang, H., Zhang, Y., Xu, H., Huang, Q., Adilijiang, A., Wang, J., Zhang, Z., Zhang, D., Tan, Q., He, J., Kong, L., Liu, Y., & Li, X.-M.
- Affiliations
- Jilin University (CN)
- Shantou University (CN)
- University of Saskatchewan (CA)
- University of Manitoba (CA)
- Zhongda Hospital Southeast University (CN)
- Peking University (CN)
- Xijing Hospital (CN)
- Corresponding author
- Liu, Ya
- Li, Xin-Min
- ORCID
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 93
- Issue
- 12-14
- Pages
- 429-434
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W1976664134
- Cited by
- 36
- References
- 52
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 6 · 2019: 4 · 2018: 2 · 2017: 6 · 2016: 1 · 2015: 4 · 2014: 2
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Manitoba Health Research Council
- Health Canada
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- antipsychotic drugs, oligodendrocyte precursor cells, oligodendrocyte differentiation, Olig1, Olig2, haloperidol, olanzapine, quetiapine, CNPase, oligodendrocyte lineage, schizophrenia, myelin
- MeSH terms
- Quetiapine Fumarate, Oligodendrocyte Transcription Factor 2, Olanzapine, Animals, Benzodiazepines, Cell Differentiation, Cell Line, Dibenzothiazepines, Haloperidol, Humans, Nerve Tissue Proteins, Oligodendroglia, Schizophrenia, Antipsychotic Agents, Gene Expression, Cell Proliferation, Mice, Rats, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Neural Stem Cells, 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review